Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Douglas Calder | M | 56 |
BioVest International, Inc.
 BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | 6 years |
| Christopher Chapman | M | 71 |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | 5 years |
| Garrison Hasara | M | 54 | 10 years | |
| Frank O'Donnell | M | 74 |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | 10 years |
| William S. Poole | M | 77 | - | |
| John Sitilides | M | 61 |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | - |
| Martin G. Baum | M | 57 |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | - |
| Priya Jambhekar | F | - | 3 years | |
| Alan M. Pearce | M | 75 |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | 6 years |
| Edmund King | M | 89 | 7 years | |
| Laurie Glimcher | M | 72 | 20 years | |
| Brian Bottjer | M | 50 |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | - |
| David Schubert | M | 57 | - | |
| Angelos Stergiou | M | 48 |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | 4 years |
| Ronald Osman | M | 78 |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | - |
| Charles Sigal | M | 72 | 16 years | |
| Raphael J. Mannino | M | 77 |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | - |
| Jeffrey Scott | M | 67 |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | - |
| Samuel Duffey | M | 78 | 10 years | |
| Anthony Hooper | M | 69 | 15 years | |
| Gerald Crabtree | M | 83 | 7 years | |
| James Sapirstein | M | 63 | 4 years | |
| Robert Roche | M | 57 | 6 years | |
| David Ian Johnson | M | 66 | 12 years | |
| Michael Tardugno | M | 73 | 2 years | |
| Todd D. Thomason | M | 56 | - | |
| Peter S. Linsley | M | 72 | 14 years | |
| Joachim von Roy | M | 79 | - | |
| Lie Ping Chen | M | - | - | |
| James A. Wachholz | M | 70 | 2 years | |
| James E. Shiah | M | 64 | 3 years | |
| Elliott Levy | M | 65 | 17 years | |
| Kenneth Anderson | M | - | 17 years | |
| Mark Reisenauer | M | 58 | 2 years | |
| Robert W. Morrissey | M | 66 | 6 years | |
| Brian Crynes | M | 77 | 3 years | |
| Dion Sullivan | M | - | 6 years | |
| Paul von Autenried | M | 62 | 26 years | |
| Douglas C. Plessinger | M | 55 | 6 years | |
| Wenqing Yao | M | 61 | 6 years | |
| Donald Handley | M | - | 3 years | |
| Lucius Allen | M | - | - | |
| William C. Reynolds | M | - | 7 years | |
| Gary Dickinson | M | 72 | 4 years | |
| Cheryl Capps | F | 62 | 13 years | |
| Larry K. Benedict | M | 63 | 7 years | |
| Laurie Alsup | M | 70 | 10 years | |
| Dmitry Borisovich Syromyatnikov | M | - | 7 years | |
| Julie Smith | F | 53 | - | |
| Beth Anne Piper | M | - | 4 years | |
| Jarrett Disbrow | M | 49 | 4 years | |
| Mike Werner | M | - | 4 years | |
| A. Collier Smyth | M | 78 | 13 years | |
| Jonathan Mow | M | 59 | 2 years | |
| Steven J. Stogel | M | - | - | |
| Barry A. Labinger | M | 60 | 3 years | |
| Carl Ray Holman | M | 82 | - | |
| Helen Torley | M | 61 | 5 years | |
| Geoffrey Gilmore | M | 58 | 11 years | |
| Kevin Rooney | M | 58 | 6 years | |
| Michael A. Popson | M | - | 6 years | |
| R. Scott Jones | M | 66 | 2 years | |
| David K. Bol | M | 58 | 6 years | |
| James R. Ellinghausen | M | 65 | 8 years | |
| Luigi Lenaz | M | 83 | 19 years | |
| Bob Daniel Weiss | M | 72 |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | 4 years |
| Sam Owusu-Akyaw | M | 71 | 2 years | |
| Nicholas J. Leb | M | - |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | - |
| James T. Crines | M | 64 | 2 years | |
| Stephane Allard | M | 70 |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | 1 years |
| Timothy P. Cost | M | 65 | 5 years | |
| Gregg L. Bienstock | M | 59 | 1 years | |
| Christine Poon | F | 71 | 3 years | |
| Carl M. Cohen | M | 76 |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | - |
| Marino Carol | F | - | 8 years | |
| Michael Loberg | M | 76 | 18 years | |
| David Redmond | M | 72 | 1 years | |
| Richard J. White | M | 82 | 12 years | |
| Rick Winningham | M | 64 | 4 years | |
| Matthew Wikler | M | 74 | 4 years | |
| Dennis L. Ryll | M | - | - | |
| Hank Safferstein | M | - | 3 years | |
| Adeoye Olukotun | M | 79 | 13 years | |
| Jaisim Shah | M | 63 | 3 years | |
| James McNulty | M | 73 |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | 4 years |
| N. Coles | M | 63 | - | |
| Mark E. McGovern | M | 70 | 11 years | |
| Giorgio Mosconi | M | 63 | 4 years | |
| Leon E. Rosenberg | M | 90 | 1 years | |
| John P. Dubinsky | M | 80 | 3 years | |
| William A. Scott | M | 84 | 6 years | |
| Nicole Onetto | M | 71 | 6 years | |
| Myrtle Potter | F | 65 | 4 years | |
| Emmanuel Blin | M | 54 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 94 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Steven R. Arikian
- Personal Network
